VVOSVivos Therapeutics, Inc.
- Market cap
- $4.49M
- as of 2026-10-23
- Latest close
- $0.13
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Medical Devices
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-06-28
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Johnson Gregg C | Sep 14 | Sep 18 | A · derivative | 12,000 | $0.18 | $2,160 | 12,000 | No | Form 4 |
| Sokolow Leonard J | Sep 14 | Sep 18 | A · derivative | 12,000 | $0.18 | $2,160 | 17,600 | No | Form 4 |
| Huntsman Ronald KirkChief Executive Officer | Jun 30 | Sep 18 | J | 85,910 | $0.58 | $49,828 | 85,910 | No | Form 4 |
| Huntsman Ronald KirkChief Executive Officer | Jun 30 | Sep 18 | J · derivative | 85,910 | $0.58 | $49,828 | 85,910 | No | Form 4 |
| Amman Bradford K.Principal Accounting Officer | Jul 31 | Aug 26 | A | 250,000 | $0.41 | $102,500 | 250,080 | No | Form 4 |
| Amman Bradford K.Principal Accounting Officer | Jul 31 | Aug 26 | A · derivative | 150,000 | $0.41 | $61,500 | 326,533 | No | Form 4 |
| Skaff Michael C | Jun 30 | Jul 15 | P · derivative | 859,166 | $0.58 | Purchase +$498,316 | 859,166 | No | Form 4 |
| Skaff Michael C | Jun 30 | Jul 15 | P · derivative | 1,890,164 | $0.58 | Purchase +$1,096,295 | 2,749,330 | No | Form 4 |
| Skaff Michael C | Jun 30 | Jul 15 | P · derivative | 2,749,330 | $0.58 | Purchase +$1,594,611 | 2,749,330 | No | Form 4 |
| V-Co Investors 3 LLC | Mar 31 | Apr 2 | P | 1,044,777 | $1.34 | Purchase +$1,400,001 | 1,044,777 | No | Form 4 |
| V-Co Investors 3 LLC | Mar 31 | Apr 2 | P | 308,848 | $1.34 | Purchase +$413,856 | 1,353,625 | No | Form 4 |
| V-Co Investors 3 LLC | Mar 31 | Apr 2 | P · derivative | 429,957 | $1.34 | Purchase +$576,142 | 429,957 | No | Form 4 |
| V-Co Investors 3 LLC | Mar 31 | Apr 2 | P · derivative | 1,783,582 | $1.34 | Purchase +$2,390,000 | 1,783,582 | No | Form 4 |
| V-Co Investors 3 LLC | Mar 31 | Apr 2 | P · derivative | 1,783,582 | $1.34 | Purchase +$2,390,000 | 1,783,582 | No | Form 4 |
| Amman Bradford K.Chief Financial Officer | Nov 26, 2024 | Nov 27, 2024 | A · derivative | 149,533 | $2.64 | $394,767 | 180,533 | No | Form 4 |
| Huntsman Ronald KirkChief Executive Officer | Nov 26, 2024 | Nov 27, 2024 | A · derivative | 315,421 | $2.64 | $832,711 | 364,755 | No | Form 4 |
| Amman Bradford K.Chief Financial Officer | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 15,000 | $2.38 | $35,700 | 31,667 | No | Form 4 |
| Green Ralph Elias | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 4,000 | $2.38 | $9,520 | 7,067 | No | Form 4 |
| Huntsman Ronald KirkChief Executive Officer | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 20,000 | $2.38 | $47,600 | 49,334 | No | Form 4 |
| Krammer Anja B | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 4,000 | $2.38 | $9,520 | 7,067 | No | Form 4 |
| Lindsay Mark F. | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 4,000 | $2.38 | $9,520 | 7,067 | No | Form 4 |
| Sokolow Leonard J | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 4,000 | $2.38 | $9,520 | 7,467 | No | Form 4 |
| Thompson Matthew | Jun 20, 2024 | Jun 28, 2024 | A · derivative | 4,000 | $2.38 | $9,520 | 7,067 | No | Form 4 |